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Abstract
Background: Herpes simplex infections (HSV1/2) are characterized by recurrent symptoms, a risk of neonatal herpes,
and the facilitation of HIV transmission. In Germany, HSV1/2 infections are not notifiable and data are scarce. A previous
study found higher HSV1/2 seroprevalences in women in East Germany than in women in West Germany. We assessed
changes in the HSV1/2 seroprevalences over time and investigated determinants associated with HSV1/2 seropositivity
to guide prevention and control.
Methods: The study was based on the German Health Interview and Examination Survey for Adults (DEGS; 2008–2011)
and the German National Health Interview and Examination Survey (GNHIES; 1997–1999). We tested serum samples
from DEGS participants for HSV1 and HSV2 immunoglobulin G. We used Pearson’s χ2 test to compare the HSV1/HSV2
seroprevalences in terms of sex, age, and region of residence (East/West Germany) and investigated potential
determinants by calculating prevalence ratios (PR) with log-binomial regression. All statistical analyses included survey
weights.
Results: In total, 6627 DEGS participants were tested for HSV1, and 5013 were also tested for HSV2. Overall, HSV1
seroprevalence decreased significantly from 1997–1999 (82.1%; 95%CI 80.6–83.6) to 2008–2011 (78.4%; 95%CI 77.
8–79.7). In the same period, overall HSV2 seroprevalence decreased significantly from 13.3% (95%CI 11.9–14.9) to
9.6% (95%CI 8.6–10.8), notably in 18–24-year-old men (10.4 to 0%) in East Germany. Women were more likely than men
to be seropositive for HSV1 (PR 1.1) or HSV2 (PR 1.6). A lower level of education, smoking, and not speaking German
were associated with HSV1 in both sexes. Women of older age, who smoked, or had a history of abortion and men of
older age or who had not attended a nursery school during childhood were more often seropositive for HSV2.
Conclusion: The reduced seroprevalences of HSV1 and HSV2 leave more people susceptible to genital HSV1/2
infections. Practitioners should be aware of HSV infection as a differential diagnosis for genital ulcers. We recommend
educational interventions to raise awareness of the sexual transmission route of HSV1/2, possible consequences, and
prevention. Interventions should especially target pregnant women, their partners, and people at risk of HIV.
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Background
Herpes simplex virus is the main cause of genital ul-
cers worldwide [1]. Both Herpes simplex virus 1
(HSV1) and Herpes simplex virus 2 (HSV2) infect the
epithelial cells of the skin and mucosa through minor
breaks, and then travel by retrograde transport to the
sensory root ganglia, where they persist throughout life
[2]. Most new infections remain undiagnosed because
they are asymptomatic or cause only short-lived symp-
toms [3]. Clinical lesions typically occur after a pri-
mary infection in about 10–25% of infections [4].
Reactivation from the latent state results in the release
of the virus from the surface of the skin or mucosa,
which is called ‘shedding’ [5]. Viral shedding can occur
with or without symptoms and leads to further trans-
mission [4]. The specific tropism of the virus means
that HSV1 predominantly infects the orolabial tissue
and is transmitted by contact with infected saliva,
which often occurs early in life [6]. HSV2 typically in-
fects the genitalia and is transmitted through sexual
contact. However, in recent decades, an increasing
proportion of genital HSV infections have been caused
by HSV1 [7–9]. Two main developments have been
suggested to be responsible for this trend: an increased
proportion of adolescents and young adults who are
HSV1 negative and therefore more susceptible to the
acquisition of HSV1 through the sexual route, and an
increased frequency of oral sex [10].
The classic clinical presentation of genital herpes
infection is characterized by erythematous papules and
vesicles on the external genitalia with pain, itching,
burning, and, especially in women, dysuria [1]. About
40% of symptomatic men and 70% of symptomatic
women present with fever, headache, malaise and my-
algias. Complications include aseptic meningitis, extra-
genital lesions and autonomic dysfunction including
urinary detention. Genital herpes can be associated
with psychosocial consequences including anger, low
self-esteem, fear of rejection by sexual partners, and
depression.
Approximately 57 and 89% of individuals with a his-
tory of primary HSV1 or HSV2 infection, respectively,
experience symptomatic HSV reactivation (recurrence)
with symptoms lasting between 5 and 10 days [1, 11].
Individuals with genital HSV2 infection experience
about four recurrences per year whereas those with
genital HSV1 infection experience about one recur-
rence per year [11]. Prospective follow-up has shown a
reduction of recurrences over time in most but not all
patients [1].
Genital herpes infection can be transmitted from
mother to child, with primary infection in a mother
close to delivery or within the last trimester being the
greatest risk [4]. Symptoms in the neonate include skin
and eye disease, encephalitis, or disseminated infection
[12]. Cognitive impairment, severe neurological disease,
organ dysfunction, and death are among the common
sequelae [1]. It has also been shown that genital herpes
increases the risk of acquiring Human immunodefi-
ciency virus (HIV), HIV transmission, and HIV progres-
sion [13, 14].
In 2012, an estimated 3709 million people aged
0–49 years were infected with HSV1 worldwide and
an estimated 417 million people aged 15–49 years
were living with HSV2, which constitutes a global
HSV1 seroprevalence of 67% and a global HSV2
seroprevalence of 11.3% [15, 16].
In the World Health Organization European region,
approximately 207 million women and 187 million
men aged 0–49 years were living with HSV1 in 2012,
corresponding to seroprevalences of 69 and 61%, re-
spectively [15]. In the same region, 21.7 million women
and 9.7 million men aged 15–49 years were estimated
to be HSV2 seropositive [16]. In national cross-
sectional serological surveys performed in European
countries between 1989 and 2000, the age-
standardized HSV1 seroprevalence ranged from 52% in
Finland to 84% in Bulgaria and the age-standardized
HSV2 seroprevalence ranged from 4% in England and
Wales to 24% in Bulgaria [17].
A German survey based on representative data col-
lected in 1997–1999 found an overall age-standardized
HSV1 seroprevalence of 82.6% and an overall HSV2
seroprevalence of 13.3% [18]. Interestingly, women res-
iding in the area of the former German Democratic
Republic (GDR), now the east of unified Germany, had
significantly higher age-adjusted seroprevalences of
HSV1 and HSV2 than women residing in the former
Federal Republic of Germany (FRG), now the west of
unified Germany. The authors of that study discussed
a potentially different sexual behavior of these women
as a possible explanation for these disparities [18].
The different political and economic system of the
GDR which ceased to exist in 1990 impacted the East
German society profoundly. The contrast between the
GDR and the FRG included differences in family plan-
ning, partner relationships and sexual behavior [19].
For example, in the GDR, sexual health education at
schools was not very common, hormonal contracep-
tion was available free of charge, and use of condoms
was less common when compared to the FRG. After
reunification, risk perception and sexual behavior of
East Germans started to change gradually. From 1990
to 2000 differences between the incidence of syphilis
(median incidence GDR vs. FRG: 2.1 vs. 1.3 per
100.000 population) and gonorrhea (median incidence
GDR vs. FRG: 7.2 vs. 4.1 per 100.000 population)
decreased from 3.5- to 1.7-fold for syphilis and from
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2.1- to 1.1-fold for gonorrhea [18]. Whereas in 1994
the number of 14–17-year-olds which affirmed to have
sexual health education at schools differed between
former GDR (around 45%) and former FRG (around
83%), in 2014 about 95% of 14–17-year-olds affirmed
to have sexual health education at their schools, re-
gardless whether they lived in the former GDR or
former FRG [20].
Given the described high seroprevalence of HSV1
and HSV2 in Germany [18] and the recurrent nature
of the infections, the clinical and psychosocial burden
of the genital ulcer disease caused by HSV is probably
very high. However, there has been little research into
genital herpes in Germany, possibly because it is not
reportable in Germany and there are no specialized
sexual health clinics with an established routine sur-
veillance strategy for sexually transmitted infections
(STIs).
In this paper, we provide recent representative data
and describe the latest developments in HSV1 and
HSV2 seroepidemiology in Germany to guide prevention
and control of HSV1/2 infections and to promote re-
search into this important public-health issue. Based on
a large nationwide representative survey undertaken in
2008–2011, we assessed the seroprevalence of HSV1 and
HSV2 in adults in Germany, compared these seropreva-
lences to the findings of a previous survey in 1997–1999,
and investigated factors such as sociodemographic vari-
ables and sexual behavior associated with HSV1 and
HSV2 seropositivity.
Methods
Study design and population
The study was based on the German National Health
Interview and Examination Survey (GNHIES) and the
German Health Interview and Examination Survey for
Adults (DEGS), which were conducted in 1997–1999
and 2008–2011, respectively [21, 22]. Both studies are
part of the national health monitoring conducted by the
Robert Koch Institute (RKI).
The GNHIES was based on a stratified, multistage,
cross-sectional, national representative sample of in-
dividuals aged 18–79 years from the noninstitutional-
ized population of Germany. It had a total of 7124
participants corresponding to a 61.5% response
proportion (18).
Nationwide representative data on the health status of
the adult (18–79 years) German resident population
were collected in the DEGS. In total, 8151 individuals
participated. The response proportion was 48.4%. The
analysis of nonresponder questionnaires revealed high
population representativeness. The survey design was
both cross-sectional and longitudinal. Almost half of all
the participants were already enrolled in the GNHIES.
Both surveys included questionnaires, physical tests,
and the collection of biomaterial. The sampling design
and data collection of both surveys are described in
detail elsewhere [21, 22]. The DEGS questionnaire in-
cluded variables involving self-reported morbidity,
medication use, symptoms and complaints, mental
health, subjective health, sex-specific health issues,
injuries, falls, functional capacities, disability, health-
related behavior, living and social conditions,
sociodemographic context variables, and health-care
services utilization. In our study, we used the follow-
ing DEGS variables: sex, age, educational classifica-
tion, income, employment status, current smoking,
number of other children in the household during
childhood, attendance at a nursery school during
childhood, degree of urbanization, region of residence,
German mother tongue, number of sexual partners in
the preceding 12 months, HSV1/2 serostatus, current
use of birth control methods (only women were
asked), miscarriage, abortion, and condom use
(women were only asked about condom use in the
context of birth control methods, so this variable
could only be used for men in terms of general safer
sex behavior).
Laboratory methods
Serum samples from the DEGS participants were
tested for HSV1 (gG1) and HSV2 (gG2) with a chemi-
luminescence immunoassay (CLIA) (LIAISON® HSV1/
2, DiaSorin, von Hevesy-Strasse 3, 63,128 Dietzen-
bach). The light signal, and hence the amount of
isoluminol-antibody conjugate, was measured by a
photomultiplier as relative light units (RLU). An index
value of <0.9 was defined as immunoglobulin G (IgG)
negative and an index value >1.1 as IgG positive.
Because retesting samples with an equivocal result for
HSV using immunoblotting usually produces a nega-
tive result and equivocal results have been classified as
negative in other seroprevalence studies [17], we
classified all of our equivocal samples (0.3% of all the
samples for HSV1 and 0.8% of all the samples for
HSV2) as negative.
In a previous seroepidemiological survey of HSV1/2,
researchers tested serum samples from 3792 GNHIES
participants with another indirect ELISA (MRL
Diagnostics, Los Angeles, CA, USA, now HerpesSelect®,
Focus Technologies, Cypress, CA, USA) [18].
It has been demonstrated that both assays compare well
in terms of their sensitivity and specificity, with almost
100% concordance in comparative analyses [23, 24].
Statistical analyses
All statistical analyses included survey weights based on
sex, age, federal state of residence, municipality size,
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nationality (German yes/no), and education level to
account for any deviations of the survey sample from
German population statistics [21].
Using the more recent survey (DEGS), we:
 calculated the overall and age- and sex-specific
HSV1 and HSV2 seroprevalences and their 95%
confidence intervals (CIs);
 used Pearson’s χ2 test to investigate the potential
associations between seroprevalence and sex, age, and
region of residence (East or West Germany); and
 investigated potential determinants associated with
HSV1/2 seropositivity by calculating the PRs using
log-binomial regression. Because the questions
concerning sexual behavior differed for men and
women, we performed the univariable and
multivariable analyses separately for each sex. If a
p-value was <0.2 in the univariable analysis, we in-
cluded that variable in a stepwise forward variable se-
lection to find a suitable multivariable model. As only
a small number of behavioral variables were available
within the survey, we set the cutoff for the p-value at
0.2 to take these variables sufficiently into account.
Two-way interaction terms were generated for bio-
logically relevant covariate pairs, and retained in the
model if significant (p ≤ 0.05).
To examine changes in the HSV1 and HSV2 seropreva-
lences between 1997–1999 and 2008–2011 in 18–64-year-
olds in Germany, we also used the HSV1 and HSV2 test
results from GNHIES and applied Pearson’s χ2 test. These
analyses were adjusted for the reparticipation rate of the
GNHIES participants in the DEGS, in addition to the
above mentioned weighting procedure [21].
All data analyses were performed with Stata 14
(Stata Statistical Software: Release 14. StataCorp LP,
College Station, TX).
Results
Characteristics of the study participants
A total of 6627 adults, representing 91.6% of the DEGS
survey population with available blood samples, were
tested for HSV1 IgG. Of these, 5013 were also tested for
HSV2 IgG. HSV1/2 were not tested in the other partici-
pants because the amount of blood available for all the
tests performed in the survey was limited. Neither the
study population tested for HSV1 nor the study popula-
tion tested for HSV2 differed from the total DEGS study
population with regard to sex, age, or region of residence.
Weighted seroprevalence of HSV1
The overall seroprevalence of HSV1 in the DEGS was
78.7% (95%CI 77.2–80.1). The HSV1 seroprevalence was
significantly higher in women (82.0%, 95%CI 80.0–83.7)
than in men (75.4%, 95%CI 73.4–77.3). HSV1 seroposi-
tivity increased with age from 46.8% (95%CI 42.4–51.2)
in the 18–24-year age group to 91.9% (95%CI 89.8–93.6)
in the 65+ −year age group. HSV1 seroprevalence was
significantly higher in residents of East Germany (81.7%,
95%CI 79.0–84.1) than in residents of West Germany
(77.9%, 95%CI 76.2–79.5). However, when stratified by
sex, this effect was only significant for women in the age
groups 35–44 years (East: 90.2%, 95%CI 84.3–94.1;
West: 80.7, 95%CI 75.3–85.1), 45–54 years (East: 91.7%,
95%CI 88.3–94.1; West: 85.1%, 95%CI 80.9–88.5), and
65+ years (East: 96.2%, 95%CI 93.3–97.9; West: 92.1,
95%CI 88.6–94.5) (Fig. 1). In women aged 25–34 and
55–64 years, the effect was reversed: the women in West
Germany had a higher HSV1 seroprevalence than their
counterparts in East Germany, although the difference
was not statistically significant.
Weighted seroprevalence of HSV2
The overall seroprevalence of HSV2 in the DEGS was
9.4% (95%CI 8.3–10.5). HSV2 seroprevalence was
Fig. 1 Weighted HSV1 seroprevalence according to sex, age and region of residence, Germany 2008–2011. *HSV1 seroprevalence differed
significantly between women and men. °HSV1 seroprevalence differed significantly between women in East Germany vs. women in West
Germany in the age groups 35–44, 45–54 and 65+
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significantly higher in women (11.7%, 95%CI 10.2–13.3)
than in men (7.2%, 95%CI 5.9–8.6). HSV2 seropositivity
increased from 1.6% (95%CI 0.8–3.2) in the 18–24-year
age group to 13.4% (95%CI 10.9–16.4) in the 55–64-year
age group, decreasing thereafter to 11.7% (95%CI 9.6–
14.2) in study participants aged 65+. The seroprevalence
of HSV2 was significantly higher in the residents of East
Germany (11.9%, 95%CI 9.9–14.3) than in the residents
of West Germany (8.7%, 95%CI 7.5–10.0). However, when
stratified by sex, only women in East Germany had a
higher seroprevalence than their counterparts in West
Germany (East: 14.6%, 95%CI 11.5–18.4; West: 10.8%,
95%CI 9.2–12.7). When stratified by age and sex, the
higher HSV2 seroprevalence in East Germany was only
significant for women aged 65+ years (East: 18.1%, 95%CI
12.2–26.0; West: 10.3%, 95%CI 7.3–14.3) and men aged
25–34 years (East: 6.2%, 95%CI 3.0–12.6; West: 1.8%;
95%CI 0.6–5.2) (Fig. 2). The opposite trend was observed
in both women and men aged 18–24 and 55–64 years, al-
though the differences were not statistically significant.
Factors associated with HSV1 seropositivity
In the DEGS, women were more likely to be HSV1 IgG
positive than men (crude prevalence ratio [CPR] 1.1;
95%CI 1.1–1.1). The results of the univariable analyses,
stratified by sex, are shown in Tables 1 and 2.
Among women, older age, a lower level of education,
being employed as a ‘worker’ rather than an ‘employee’,
smoking, and not speaking German as a first language
were associated with HSV1 seropositivity in the multi-
variable model (Table 1).
Among men, older age, a lower level of education,
smoking, more than two other children in the household
during childhood, residence in East Germany, and not
speaking German as a first language were associated
with HSV1 seropositivity in the multivariable model
(Table 2). We found no significant interactions among
the relevant covariate pairs for either men or women.
Factors associated with HSV2 seropositivity
Women were also more likely to be seropositive for
HSV2 than men (CPR 1.6; 95%CI 1.3–2.0). The results
of the univariable analysis, stratified by sex, are shown in
Tables 3 and 4. We found that older age, smoking, and a
history of abortion were associated with HSV2 seroposi-
tivity in women (Table 3) and that older age, not attend-
ing a nursery school during childhood, and the
occasional use of condoms (as opposed to their consist-
ent use) were associated with HSV2 seropositivity in
men (Table 4). We found no relevant covariate pairs.
Changes in HSV1 seroprevalence from 1997–1999 to
2008–2011
Since the GNHIES survey in 1997–1999, the overall
seropositivity for HSV1 in Germany has declined statisti-
cally significantly (Fig. 3a–d). Whereas the total adult
HSV1 seroprevalence was 82.1% (95%CI 80.6–83.6) in
the GNHIES, it was 78.4% (95%CI 77.8–79.7) in the
DEGS. The decline was significant in men (1997–1999:
80.7%, 95%CI 78.7–82.5; 2008–2011: 75.3%, 95%CI
73.3–77.1) but not in women (1997–1999: 83.7%, 95%CI
81.4–85.8; 2008–2011: 81.6%, 95%CI 79.8–83.3). When
stratified by region of residence, the decline was signifi-
cant in both men (1997–1999: 83.6, 95%CI 81.0–86.0;
2008–2011: 77.7%, 95%CI 73.8–81.1) and women
(1997–1999: 88.7%, 95%CI 86.0–91.0; 2008–2011: 83.3%,
95%CI 79.8–86.3) in East Germany, but only for men in
West Germany (1997–1999: 79.5%, 95%CI 77.0–81.8;
2008–2011: 74.6%, 95%CI 72.3–76.7) (Fig. 3a).
In the group aged 18–24 years, HSV1 seropositivity
declined from 64.0% (95%CI 59.1–68.5) in 1997–1999 to
46.7% (95%CI 42.4–51.1) in 2008–2011 (Fig. 3b). This
effect was significant for both sexes, but more
Fig. 2 Weighted HSV2 seroprevalence according to sex, age and region of residence, Germany 2008–2011. *HSV2 seroprevalence differed significantly
between women and men. °HSV2 seroprevalence differed significantly between 25-34 year old men in East vs. West Germany and in
women aged 65+ in East vs. West Germany. #There were no HSV2 positive results among 18-24 year old male study participants living in East Germany
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Table 1 Associations between variables and HSV1 seropositivity in women, Germany 2008–2011
Variables N Weighteda prevalence % (95% CI) Univariable Analysis Multivariable Analysis
PRb(95% CI) p-value PRc(95% CI) p-value
Age group (years)
18–24 283 51.4 (45.3–57.5) Ref Ref Ref Ref
25–34 400 70.4 (64.6–75.5) 1.4 (1.2–1.6) 0.000 1.2 (1.0–1.4) 0.057
35–44 519 82.4 (77.9–86.1) 1.6 (1.4–1.8) 0.000 1.4 (1.2–1.6) 0.000
45–54 714 86.5 (83.1–89.2) 1.7 (1.5–1.9) 0.000 1.4 (1.2–1.7) 0.000
55–64 630 91.8 (88.7–94.1) 1.8 (1.6–2.0) 0.000 1.5 (1.3–1.8) 0.000
65+ 895 93.1 (90.4–95.1) 1.8 (1.6–2.0) 0.000 1.6 (1.3–1.8) 0.000
CASMIN educational classification
Low 1117 90.0 (87.6–91.9) 1.3 (1.2–1.4) 0.000 1.2 (1.1–1.3) 0.000
Medium 1772 79.3 (76.4–82.0) 1.2 (1.1–1.2) 0.000 1.2 (1.1–1.3) 0.000
High 531 68.8 (63.7–73.5) Ref Ref Ref Ref
Income
Low 991 83.4 (80.1–86.2) Ref Ref − −
Medium 2031 82.0 (79.7–84.2) 1.0 (0.9–1.0) 0.481 − −
High 419 76.9 (70.6–82.2) 0.9 (0.8-1.0) 0.066 − −
Employment situation
Worker 827 91.2 (88.5–93.4) 1.1 (1.1–1.2) 0.000 1.1 (1.0–1.1) 0.004
Employee 1611 81.4 (78.5–83.9) Ref Ref Ref Ref
Civil servant 169 70.3 (60.5–78.5) 0.9 (0.8–1.0) 0.036 0.9 (0.8–1.1) 0.482
Free-lance/self-reliant 233 84.9 (77.9–90.0) 1.0 (1.0–1.1) 0.232 1.0 (1.0–1.1) 0.379
Family worker 64 87.5 (75.2–94.1) 1.1 (1.0–1.2) 0.201 1.0 (0.9–1.2) 0.551
other 124 51.8 (40.9–62.5) 0.6 (0.5–0.8) 0.000 0.8 (0.6–1.0) 0.086
Smoking, currently
Daily 643 84.2 (80.0–87.7) 1.0 (1.0–1.1) 0.266 1.1 (1.0–1.1) 0.035
Occasionally 179 75.1 (67.2–81.6) 0.9 (0.8-1.0) 0.090 1.1 (1.0–1.2) 0.023
No, not anymore 825 82.1 (77.7–85.7) 1.0 (1.0–1.1) 0.841 1.0 (0.9–1.1) 0.898
Never smoked 1776 81.6 (79.1–83.9) Ref Ref Ref Ref
Number of other children in household during childhood
0 369 76.6 (70.6–81.7) Ref Ref − −
1–2 1478 74.9 (71.9–77.7) 1.0 (0.9–1.1) 0.579 − −
> 2 1594 90.6 (88.5–92.3) 1.2 (1.1–1.3) 0.000 − −
Visit of nursery during childhood
No 801 87.9 (84.4–90.7) 1.2 (1.1–1.2) 0.000 − −
Yes 1705 74.8 (71.9–77.5) Ref Ref − −
Degree of urbanization
Rural 607 83.8 (78.3–88.2) Ref Ref − −
Provincial 844 84.0 (80.1–87.3) 1.0 (0.9–1.1) 0.956 − −
Urban 963 80.2 (76.3–83.6) 1.0 (0.8–1.0) 0.238 − −
Metropolitan 1027 81.1 (77.7–84.0) 1.0 (0.9–1.0) 0.347 − −
Region of residence
West Germany 2350 81.2 (78.9–83.2) Ref Ref − −
East Germany (including Berlin) 1091 85.0 (81.4–88.0) 1.0 (1.0-1.1) 0.052 − −
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pronounced in men (1997–1999; 63.1%, 95%CI 57.4–
68.5; 2008–2011: 41.9%, 95%CI 35.5–48.6) than in
women (1997–1999: 64.8%, 95%CI 58.1–71.0; 2008–
2011: 51.6%, 95%CI 45.6–57.6) in this age group. When
stratified by region of residence, HSV1 seroprevalence
declined significantly from 71.9% (95%CI 60.4–81.0) to
41.8% (95%CI 27.2–58.0) among 18–24-year-old men in
East Germany, from 61.1% (95%CI 54.6–67.2) to 41.9%
(95%CI 35.0–49.2) among 18–24-year-old men in West
Germany, and from 64.3% (95%CI 56.5–71.5) to 49.7%
(95%CI 42.8–56.6) among 18–24-year-old women in
West Germany. Among 18–24-year-old women in East
Germany, the decline in HSV1 seropositivity from 66.8%
(95%CI 54.3–77.3) to 59.6% (95%CI 48.0–70.2) was not
significant.
In 1997–1999, women aged 25–44 years in East
Germany were more likely to be HSV1 seropositive
(86.7%, 95%CI 81.9–90.3) than their counterparts in West
Germany (83.1%, 95%CI 78.2–87.1), but the situation was
reversed in 2008–2011 (East Germany: 72.5%, 95%CI
63.2–80.2; West Germany: 76.7%, 95%CI 72.6–80.4) (Fig.
3c). HSV1 Seropositivity in men aged 25–44 years de-
creased in East Germany (81.3%, 95%CI 76.8–85.1 to
71.8%, 95%CI 64.8–77.8) and West Germany (79.1%,
95%CI 74.2–83.2 to 68.8%, 95%CI 64.1–73.1).
Changes in HSV2 seroprevalence from 1997–1999 to
2008–2011
The overall HSV2 seropositivity in Germany de-
creased significantly from 13.3% (95%CI 11.9–14.9) to
Table 1 Associations between variables and HSV1 seropositivity in women, Germany 2008–2011 (Continued)
German mother tongue
Yes 3170 81.0 (78.9–83.0) Ref Ref Ref Ref
No 242 88.4 (82.2–92.6) 1.1 (1.0–1.2) 0.000 1.1 (1.1–1.2) 0.000
Number of sexual partners in last 12 months
None 1051 85.4 (82.3–88.0) 1.0 (1.0–1.1) 0.043 − −
1 2110 81.5 (78.9–83.9) Ref Ref − −
2–3 153 62.3 (53.1–70.7) 0.8 (0.7–0.9) 0.001 − −
> 3 24 76.6 (49.1–91.8) 0.9 (0.7–1.2) 0.668 − −
HSV2 serostatus
HSV2 seronegative 2262 81.6 (79.1–83.8) Ref Ref − −
HSV2 seropositive 323 88.9 (83.7–92.6) 1.1 (1.0–1.2) 0.004 − −
Current use of birth control methods
Yes 978 72.0 (68.5–75.3) Ref Ref − −
No 1523 84.1 (81.6–86.3) 1.2 (1.1–1.2) 0.000 − −
Which birth control method
-Contraceptive pill
Yes 470 67.2 (62.1–72.0) Ref Ref − −
No 478 77.1 (72.1–81.5) 1.1 (1.0–1.3) 0.005 − −
-Condoms
Yes 287 71.8 (65.3–77.6) Ref Ref − −
No 661 72.3 (67.9–76.4) 1.0 (0.9–1.1) 0.891 − −
Miscarriage
None 2008 77.1 (74.5–79.5) Ref Ref − −
1 or more 549 88.3 (83.8–91.6) 1.1 (1.1–1.2) 0.000 − −
Abortion
None 2047 77.3 (74.8–79.7) Ref Ref − −
1 or more 471 88.5 (84.0–91.9) 1.1 (1.1–1.2) 0.000 − −
In italics: PR is statistically significant (p < 0.05)
aWe used survey weights to account for deviations of the survey sample from the sampling parameters (i.e. age, sex, region, urban/rural region, community size,
citizenship and education)
bIf a p-value was <0.2 in the univariable analysis, we included that variable in a stepwise forward variable selection to find a suitable multivariable model
cAdjusted prevalence rates (PR) of variables which stayed in the final model (p-value ≤0.05) are reported
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Table 2 Associations between variables and HSV1 seropositivity in men, Germany 2008–2011
Variables N Weighteda prevalence % (95% CI) Univariable Analysis Multivariable Analysis
PRb (95% CI) p-value PRc (95% CI) p-value
Age group (years)
18–24 289 42.2 (35.8–48.9) Ref Ref Ref Ref
25–34 364 64.5 (58.4–70.2) 1.5 (1.3–1.8) 0.000 1.5 (1.2–1.8) 0.000
35–44 448 72.8 (67.1–77.9) 1.7 (1.5–2.0) 0.000 1.7 (1.4–2.0) 0.000
45–54 627 81.2 (77.1–84.6) 1.9 (1.6–2.3) 0.000 1.9 (1.6–2.2) 0.000
55–64 559 85.9 (81.8–89.2) 2.0 (1.7–2.4) 0.000 2.0 (1.7–2.3) 0.000
65+ 899 90.6 (87.5–92.9) 2.1 (1.8–2.5) 0.000 1.9 (1.6–2.3) 0.000
CASMIN educational classification
Low 1045 85.2 (82.2–87.7) 1.2 (1.1–1.3) 0.000 1.2 (1.1–1.2) 0.000
Medium 1407 69.7 (66.4–72.8) 1.0 (0.9–1.1) 0.967 1.1 (1.0–1.2) 0.062
High 714 69.8 (65.0–74.2) Ref Ref Ref Ref
Income
Low 855 79.1 (75.6–82.2) Ref Ref − −
Medium 1837 74.2 (71.6–76.6) 0.9 (0.9–1.0) 0.015 − −
High 494 72.3 (67.1–76.9) 0.9 (0.8–1.0) 0.022 − −
Employment situation
Worker 1109 80.2 (77.0–83.0) 1.1 (1.0–1.2) 0.004 − −
Employee 1033 73.2 (69.4–76.8) Ref Ref − −
Civil servant 224 76.2 (68.3–82.6) 1.0 (0.9–1.2) 0.462 − −
Free-lance/self-reliant 394 78.6 (72.0–84.0) 1.1 (1.0-1.2) 0.133 − −
Family worker 6 100.0 1.4 (1.3–1.4) 0.002 − −
Other 93 48.0 (35.7–60.5) 0.7 (0.5–0.9) 0.000 − −
Smoking, currently
Daily 706 76.1 (72.0–79.8) 1.1 (1.0–1.2) 0.040 1.1 (1.0–1.1) 0.060
Occasionally 201 74.0 (65.4–81.1) 1.0 (0.9–1.2) 0.440 1.1 (1.0–1.3) 0.013
No, not anymore 1181 79.5 (76.2–82.4) 1.1 (1.1–1.2) 0.000 1.0 (0.9–1.1) 0.985
Never smoked 1081 70.6 (66.7–74.2) Ref Ref Ref Ref
Number of other children in household during childhood
0 341 70.0 (63.5–75.7) Ref Ref Ref Ref
1–2 1323 64.8 (61.7–67.7) 0.9 (0.8-1.0) 0.127 0.9 (0.9–1.0) 0.184
> 2 1522 88.1 (86.0–90.0) 1.3 (1.1–1.4) 0.000 1.1 (1.0–1.2) 0.039
Visit of nursery during childhood
No 726 80.5 (76.8–83.7) Ref Ref − −
Yes 152 67.1 (64.1–70.0) 1.2 (1.1–1.3) 0.000 − −
Degree of urbanization
Rural 636 77.2 (73.2–80.7) Ref Ref − −
Provincial 799 77.3 (73.3–80.8) 1.0 (0.9–1.1) 0.974 − −
Urban 866 72.8 (68.8–76.4) 0.9 (0.9-1.0) 0.105 − −
Metropolitan 885 75.3 (71.6–78.8) 1.0 (0.9–1.0) 0.490 − −
Region of residence
West Germany 2151 74.6 (72.3–76.7) Ref Ref Ref Ref
East Germany (including Berlin) 1035 78.4 (74.5–81.9) 1.1 (1.0-1.1) 0.075 1.1 (1.0–1.1) 0.003
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9.6% (95%CI 8.6–10.8) in these years (Fig. 4a–d). The
decline was significant for both women (1997–1999:
16.0%, 95%CI 13.9–18.4; 2008–2011: 12.1%, 95%CI
10.6–13.7) and men (1997–1999: 10.9%, 95%CI 9.2–
12.8; 2008–2011: 7.3%, 95%CI 6.0–8.8). When strati-
fied by region of residence, the decline was significant
in both East Germany (1997–1999: 17.1%, 95%CI
14.9–19.6; 2008–2011: 12.8%, 95%CI 10.7–15.3) and
West Germany (1997–1999: 11.8%, 95%CI 10.1–13.7;
2008–2011: 8.8%, 95%CI 7.6–10.1).
In the study participants aged 18–24 years at the time of
the surveys, there was a decline in HSV2 seroprevalence
from 4.2% (95%CI 2.6–6.5) to 1.6% (95%CI 0.8–3.3). No
change in HSV2 seroprevalence was observed in this
age group when the study participants lived in West
Germany (men: from 1.6% [95%CI 0.6–4.1] to 1.5%
[95%CI 0.5–4.8]; women: 2.2% [95%CI 0.7–6.9] to 2.2%
[95%CI 0.8–6.0]), but in East Germany, HSV2 seroposi-
tivity for men declined from 10.4% (95%CI 5.5–18.9) to
0% and for women from 17.6% (95%CI 10.0–29.0) to
1.6% (95%CI 0.2–10.0) (Fig. 4b).
In the age group 25–44 years, HSV2 seropositivity
dropped from 14.4% (95%CI 12.4–16.7) to 6.5% (95%CI
5.1–8.4), and when stratified by sex and region of resi-
dence, this reduction was significant for women in East
Germany (from 23.2% [95%CI 17.9–29.5] to 11.4% [95%CI
7.2–17.4]), women in West Germany (from 16.9% [95%CI
13.2–21.8] to 9.1% [95%CI 6.4–12.7]), and men in West
Germany (from 9.4% [95%CI 6.5–13.4] to 3.0% [95%CI
1.4–6.0]), but not for men in East Germany (from 12.6%
[95%CI 9.8–16.0] to 7.6% [95%CI 4.2–13.4]) (Fig. 4c).
Discussion
Based on two population-based surveys, we estimated
that the HSV1 seroprevalence in adult Germans de-
creased from 82.1% in 1997–1999 to 78.4% in 2008–
2011. Declines in HSV1 seroprevalence have been seen
in many countries worldwide, including the USA [25],
England and Wales [26], Israel [27], and the Netherlands
[28]. Fewer siblings in industrialized countries, less-
crowded institutions, improvements in living conditions,
and better hygiene have been suggested to explain for
these declines [25]. We assume that many factors con-
tributed to the decrease of HSV1 seroprevalence in
Germany. The increasing number of single households
(35% in 1998, 40% in 2010) and the decreasing number
of households with three or more generations in
Germany (by 41% between 1995 and 2015) [29] could
have generally led to a reduced chance to transmit the
virus. Hypotheses concerning the sexual transmission
routes include the increased use of condoms in young
adults (women from 68% to 75%, men from 55% to 76%
between 1998 and 2009) and a higher coverage of sexual
health education at schools [20].
A reduced seroprevalence of HSV1 has also been
linked to more symptomatic HSV2 infections and more
cases of genital HSV1, both of which pose a threat to ne-
onates whose mothers acquire the infection in the third
Table 2 Associations between variables and HSV1 seropositivity in men, Germany 2008–2011 (Continued)
German mother tongue
Yes 2952 73.8 (71.7–75.8) Ref Ref Ref Ref
No 208 86.7 (79.6–91.6) 1.2 (1.1–1.3) 0.000 1.2 (1.1–1.3) 0.000
Number of sexual partners in last 12 months
None 632 74.1 (68.6–78.9) 1.0 (0.9–1.0) 0.414 − −
1 2113 76.4 (74.0–78.6) Ref Ref − −
2–3 205 65.2 (57.1–72.5) 0.9 (0.7–1.0) 0.012 − −
> 3 98 68.8 (57.0–78.6) 0.9 (0.8-1.1) 0.193 − −
HSV2 serostatus
HSV2 seronegative 2221 74.8 (72.5–76.9) Ref Ref − −
HSV2 seropositive 207 77.4 (69.6–83.6) 1.0 (0.9–1.1) 0.472 − −
Use of condoms
Generally 398 59.3 (53.7–64.7) Ref Ref − −
Occasionally 400 67.5 (61.6–73.0) 1.1 (1.0-1.3) 0.034 − −
No 1881 78.0 (77.3–82.4) 1.3 (1.2–1.5) 0.000 − −
N/a 372 79.1 (72.6–84.3) 1.3 (1.2–1.5) 0.000 − −
In italics: PR is statistically significant (p < 0.05)
aWe used survey weights to account for deviations of the survey sample from the sampling parameters (i.e. age, sex, region, urban/rural region, community size,
citizenship and education)
bIf a p-value was <0.2 in the univariable analysis, we included that variable in a stepwise forward variable selection to find a suitable multivariable model
cAdjusted prevalence rates (PR) of variables which stayed in the final model (p-value ≤0.05) are reported
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Table 3 Associations between variables and HSV2 seropositivity in women, Germany 2008–2011
Variables N Weighteda prevalence % (95% CI) Univariable Analysis Multivariable Analysis
PRb (95% CI) p-value PRc (95% CI) p-value
Age group (years)
18–24 227 2.0 (0.8–4.8) Ref Ref Ref Ref
25–34 277 7.6 (4.5–12.5) 3.9 (1.4–11.1) 0.012 3.5 (1.2–10.4) 0.021
35–44 405 11.5 (7.9–16.4) 5.9 (2.3–15.2) 0.000 5.6 (2.1–14.7) 0.001
45–54 535 16.1 (12.8–20.0) 8.2 (3.2–21.2) 0.000 7.3 (2.7–19.5) 0.000
55–64 461 15.5 (12.0–19.8) 7.9 (3.3–18.9) 0.000 8.0 (3.1–20.5) 0.000
65+ 680 12.3 (9.4–15.6) 6.3 (2.4–16.3) 0.000 6.5 (2.5–17.0) 0.000
CASMIN educational classification
Low 841 10.5 (8.2–13.3) 1.2 (0.7–1.8) 0.522 − −
Medium 1335 12.6 (10.6–15.0) 1.4 (0.9-2.1) 0.131 − −
High 392 9.1 (6.3–13.0) Ref Ref − −
Income
Low 750 10.8 (8.2–14.1) Ref Ref − −
Medium 1529 11.7 (9.8–13.8) 1.1 (0.8–1.5) 0.652 − −
High 306 14.5 (10.2–20.2) 1.3 (0.9–2.1) 0.204 − −
Employment situation
Worker 623 12.4 (9.6–16.0) 1.0 (0.7–1.3) 0.884 − −
Employee 1174 12.7 (10.5–15.4) Ref Ref − −
Civil servant 128 14.5 (8.6–23.4) 1.1 (0.7–1.9) 0.623 − −
Free-lance/self-reliant 174 13.2 (8.3–20.5) 1.0 (0.6–1.7) 0.874 − −
Family worker 47 5.3 (1.4–18.8) 0.4 (0.1–1.6) 0.202 − −
Other 96 4.0 (1.4–10.8) 0.3 (0.1–0.9) 0.033 − −
Smoking, currently
Daily 486 15.2 (11.8–19.2) 1.5 (1.1–2.1) 0.006 1.6 (1.0–2.4) 0.033
Occasionally 133 8.7 (4.9–15.1) 0.9 (0.5–1.6) 0.673 1.1 (0.5–2.3) 0.847
No, not anymore 607 13.4 (10.6–16.5) 1.3 (1.0–1.8) 0.031 1.2 (0.9–1.7) 0.226
Never smoked 1345 9.9 (8.1–12.0) Ref Ref Ref Ref
Number of other children in household during childhood
0 272 12.5 (8.2–18.6) Ref Ref − −
1–2 1125 9.6 (8.0–11.6) 0.8 (0.5–1.2) 0.221 − −
> 2 1188 13.6 (11.1–16.5) 1.1 (0.7–1.7) 0.728 − −
Visit of nursery during childhood
No 614 14.5 (11.7–17.8) 1.5 (1.1–2.0) 0.008 − −
Yes 1264 9.7 (7.8–12.0) Ref Ref − −
HSV1 serostatus
HSV1 seronegative 431 7.3 (4.8–11.1) Ref Ref − −
HSV1 seropositive 2154 12.6 (10.9–14.5) 1.7 (1.1–2.7) 0.017 − −
Degree of urbanization
Rural 424 9.6 (6.2–14.6) Ref Ref − −
Provincial 651 11.3 (8.5–14.7) 1.2 (0.7–2.0) 0.539 − −
Urban 792 10.1 (8.0–12.7) 1.1 (0.6–1.7) 0.835 − −
Metropolitan 718 14.4 (11.7–17.7) 1.5 (0.9-2.4) 0.095 − −
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trimester of pregnancy [1, 30]. Therefore, the decline in
HSV1 seroprevalence, especially its decline in young
adults, is of concern.
We estimated a decline in the seroprevalence of HSV2
in adult Germans from 13.3% in 1997–1999 to 9.6% in
2008–2011. A reduction in HSV2 seroprevalence be-
tween 1984 and 2002 has also been reported in young
adults in Israel [28, 27]. Although reductions in HSV2
seroprevalence were observed in 20–24-year-old men
and 15–19-year-old women in the Netherlands between
1995– 1996 and 2006–2007 (14), the overall seropreva-
lence of HSV2 in the Netherlands remained stable dur-
ing that period (14). In the USA, HSV2 seroprevalence
did not change significantly between 1999 and 2010
[25]. The reduced seroprevalence of HSV2 in Germany
leave more people susceptible to genital HSV infections
which, again, especially combined with the reduced
HSV1 seroprevalence, is a threat to neonates whose
mothers acquire the infection in the third trimester of
pregnancy [1, 30].
The seroprevalence of both HSV1 and HSV2 was higher
in women than in men in Germany. The greater biological
susceptibility of women to infection by genital transmis-
sion is well known [4]. Because the genital disease is more
likely to be asymptomatic in men [31], men are likely to
be underdiagnosed and to continue to engage in sexual
activities, increasing male-to-female transmission. We
found increasing seroprevalence of both HSV1 and HSV2
with increasing age, which is consistent with other studies
and correlates with cumulative exposure [17, 32].
Less-educated women and men were more likely to be
HSV1 seropositive in our study. It is well known that
Table 3 Associations between variables and HSV2 seropositivity in women, Germany 2008–2011 (Continued)
Region of residence
West Germany 1778 10.8 (9.2–12.7) Ref Ref − −
East Germany (including Berlin) 807 14.6 (11.5–18.4) 1.3 (1.0–1.8) 0.037 − −
German mother tongue
Yes 2390 11.5 (9.9–13.3) Ref Ref − −
No 172 10.9 (6.9–16.8) 0.9 (0.8–1.5) 0.825 − −
Number of sexual partners in last 12 months
None 788 12.7 (10.2–15.7) 1.1 (0.8–1.5) 0.500 − −
1 1588 11.5 (9.6–13.7) Ref Ref − −
2–3 116 12.0 (5.3–24.8) 1.0 (0.5–2.3) 0.917 − −
> 3 17 10.3 (1.4–49.0) 0.9 (0.1–6.2) 0.912 − −
Current use of birth control methodsd
Yes 740 8.5 (6.3–11.3) Ref Ref − −
No 1140 14.1 (12.0–16.6) 1.7 (1.2–2.3) 0.003 − −
Which birth control method
-Contraceptive Pill
Yes 363 7.0 (4.4–10.8) Ref Ref − −
No 353 9.6 (6.5–14.0) 1.4 (0.8–2.4) 0.264 − −
-Condoms
Yes 217 8.0 (4.7–13.4) Ref Ref − −
No 499 8.4 (5.7–12.3) 1.0 (0.5–2.1) 0.892 − −
Miscarriage
None 1504 10.4 (8.5–12.6) Ref Ref − −
1 or more 424 15.9 (12.1–20.6) 1.5 (1.1–2.1) 0.009 − −
Abortion
None 1538 10.1 (8.4–12.2) Ref Ref Ref Ref
1 or more 351 20.1 (15.3–25.9) 2.0 (1.4–2.7) 0.000 1.5 (1.1–2.2) 0.023
In italics: PR is statistically significant (p < 0.05)
aWe used survey weights to account for deviations of the survey sample from the sampling parameters (i.e. age, sex, region, urban/rural region, community size,
citizenship and education)
bIf a p-value was <0.2 in the univariable analysis, we included that variable in a stepwise forward variable selection to find a suitable multivariable model
cAdjusted prevalence rates (PR) of variables which stayed in the final model (p-value ≤0.05) are reported
dWomen older than 65 years of age were not asked about their current use of birth control methods
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Table 4 Associations between variables and HSV2 seropositivity in men, Germany 2008–2011
Variables N Weighteda prevalence % (95% CI) Univariable Analysis Multivariable Analysis
PRb (95% CI) p-value PRc (95% CI) p-value
Age group (years)
18–24 222 1.2 (0.4–3.9) Ref Ref Ref Ref
25–34 283 2.8 (1.4–5.3) 2.3 (0.6–9.0) 0.247 2.0 (0.5–7.8) 0.314
35–44 343 4.3 (2.2–8.2) 3.5 (0.9-13.9) 0.075 3.1 (0.8–12.0) 0.100
45–54 477 9.4 (6.3–13.8) 7.7 (2.5–24.0) 0.000 5.4 (1.7–17.1) 0.004
55–64 418 11.4 (8.2–15.7) 9.3 (2.8–31.2) 0.000 6.9 (2.1–23.1) 0.002
65+ 685 11.0 (8.1–14.8) 9.0 (2.6–31.1) 0.001 d d
CASMIN educational classification
Low 806 8.7 (6.4–11.8) 1.1 (0.7–1.7) 0.768 − −
Medium 1069 5.7 (4.3–7.5) 0.7 (0.4-1.1) 0.109 − −
High 538 8.2 (5.8–11.4) Ref Ref − −
Income
Low 656 6.1 (4.3–8.6) Ref Ref − −
Medium 1414 7.2 (5.7–9.2) 1.2 (0.8–1.8) 0.374 − −
High 358 9.5 (6.1–14.4) 1.6 (0.9-2.8) 0.127 − −
Employment situation
Worker 844 7.9 (5.8–10.7) 1.0 (0.6–1.5) 0.890 − −
Employee 773 8.1 (6.0–10.9) Ref Ref − −
Civil servant 183 7.0 (3.7–12.8) 0.9 (0.4–1.7) 0.659 − −
Free-lance/self-reliant 293 8.5 (5.6–12.5) 1.0 (0.6–1.8) 0.880 − −
Family worker 4 − − − − − −
Other 64 0.9 (0.1–6.5) 0.1 (0.1–0.1) 0.031 − −
Smoking, currently
Daily 524 6.3 (4.3–9.2) 0.9 (0.6–1.5) 0.761 − −
Occasionally 151 3.8 (1.7–8.2) 0.6 (0.2-1.3) 0.182 − −
No, not anymore 899 9.0 (6.8–11.7) 1.3 (1.0-1.8) 0.089 − −
Never smoked 843 6.8 (5.1–9.0) Ref Ref − −
Number of other children in household during childhood
0 257 5.5 (3.2–9.3) Ref Ref − −
1–2 999 5.8 (4.3–7.9) 1.1 (0.6–1.9) 0.839 − −
> 2 1172 8.9 (7.2–11.1) 1.6 (0.9-2.8) 0.087 − −
Visit of nursery during childhoodd
No 561 10.8 (7.9–14.5) 2.4 (1.7–3.5) 0.000 1.5 (1.0–2.2) 0.036
Yes 1153 4.4 (3.4–5.8) Ref Ref Ref Ref
HSV1 serostatus
HSV1 seronegative 548 6.5 (4.6–9.0) Ref Ref − −
HSV1 seropositive 1880 7.4 (6.0–9.1) 1.1 (0.8–1.7) 0.494 − −
Degree of urbanization
Rural 435 6.5 (3.2–12.6) Ref Ref − −
Provincial 620 6.1 (3.9–9.4) 0.9 (0.4–2.1) 0.875 − −
Urban 712 7.7 (5.7–10.3) 1.2 (0.6–2.5) 0.660 − −
Metropolitan 661 7.9 (6.2–10.2) 1.2 (0.6–2.5) 0.582 − −
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education plays an important role in the prevention of
infections. A lower level of education is probably associ-
ated with a lower parental income and cheaper housing
during childhood, although we did not examine these re-
lationships in our survey. HSV1 acquisition is also
known to be linked to socioeconomic status and a
crowded living environment [33]. Interestingly, com-
pared with never-smokers, women and men in our sur-
vey who currently smoked were more likely to be HSV1
seropositive, which may be attributable to the usually
lower socioeconomic status of smokers [34] or reflect
the lowered (local) immune response caused by cigarette
smoking. Not speaking German as the first language was
also associated with HSV1 seropositivity in both sexes.
However, the DEGS did not adequately represent non-
Germans and the number of study participants was low
in the subset of non-German speakers (Tables 1 and 2).
Smoking was associated with HSV2 seropositivity in
women but not in men when the data were adjusted for
age. Interestingly, women who had had one or more
abortion were 1.5 times more likely to be HSV2 sero-
positive. Genital herpes is not an indication for medically
induced abortion [35]. We strongly encourage further
studies to analyze this finding [36, 37]. In men, the mul-
tivariable analysis revealed a positive association between
HSV2 IgG and not having attended a nursery school
during childhood, which is consistent with the theory
that low exposure to HSV1 during childhood increases
the risk of genital HSV2 (or HSV1) acquisition later in
life [38]. However, we found no correlation between
HSV1 serostatus and HSV2 serostatus in the multivari-
able analysis. Men who only occasionally used condoms
were more likely to be HSV2 seropositive than men who
consistently used condoms. However, men who did not
use condoms at all were not more likely to be HSV2
seropositive than men who consistently used condoms.
In a previous survey based on the GNHIES data from
1997 to 1999, HSV2 seroprevalence was higher in
women living in East Germany than in women living in
West Germany [18]. Although we still observed this
trend in the older age groups in the survey performed in
2008–2011, there was a remarkable decline in HSV2
seroprevalence between 1997–1999 and 2008–2011 in
both women and men aged 18–24 years residing in East
Germany. In this age group, HSV2 seroprevalence no
longer differed between East and West Germany, regard-
less of sex. Because young people aged 18–24 years in
2008–2011 were born and raised around the time of the
reunification of Germany in 1990, this finding may be
partly attributable to the change in attitude to the pre-
vention of sexually transmitted diseases and the change
in sexual behavior in East Germany since 1990. In the
former GDR, hormonal contraception was predominant
and available free of charge from the age of 14 years
[19]. After reunification, the pill only remained free for
women under the age of 20 years and condoms became
Table 4 Associations between variables and HSV2 seropositivity in men, Germany 2008–2011 (Continued)
Region of residence
West Germany 1675 6.6 (5.2–8.4) Ref Ref − −
East Germany (including Berlin) 753 9.2 (7.0–11.9) 1.4 (1.0-2.0) 0.070 − −
German mother tongue
Yes 151 7.4 (6.1–8.9) Ref Ref − −
No 2256 5.7 (3.2–9.9) 0.8 (0.4–1.4) 0.394 − −
Number of sexual partners in last 12 months
None 486 8.3 (5.5–12.3) 1.1 (0.7–1.8) 0.594 − −
1 1613 7.3 (5.8–9.1) Ref Ref − −
2–3 155 5.3 (2.6–10.7) 0.7 (0.3–1.5) 0.395 − −
> 3 73 6.9 (2.8–16.2) 0.9 (0.4–2.4) 0.905 − −
Use of condoms
Generally 289 2.7 (1.5–4.9) Ref Ref Ref Ref
Occasionally 314 6.8 (4.2–10.8) 2.5 (1.1–5.7) 0.024 2.3 (1.0–5.1) 0.050
No 1454 8.0 (6.4–9.9) 3.0 (1.6–5.5) 0.001 1.7 (0.9–3.2) 0.105
N/a 275 9.9 (5.7–16.5) 3.7 (1.6–8.6) 0.003 1.6 (0.6–4.7) 0.345
In italics: PR is statistically significant (p < 0.05)
aWe used survey weights to account for deviations of the survey sample from the sampling parameters (i.e. age, sex, region, urban/rural region, community size,
citizenship and education)
bIf a p-value was <0.2 in the univariable analysis, we included that variable in a stepwise forward variable selection to find a suitable multivariable model
cAdjusted prevalence rates (PR) of variables which stayed in the final model (p-value ≤0.05) are reported
dMen older than 65 years of age were not asked whether they visited a nursery
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more easily available and more popular in East Germany.
Moreover, in East Germany before 1990, adolescents
tended to establish a family to gain the right to rent an
apartment, whereas remaining single became popular
after reunification because a flexible and independent
individual has a greater chance of employment in the
free market economy. Reunification also brought
changes in the abortion law, the perception of homosexu-
ality, divorce, prostitution, and pornography. Altogether,
these changes probably resulted in a higher awareness
of HIV, greater condom use, and consequently fewer
HSV2 infections in the 18–24-year-olds residing in
East Germany.
There were a number of limitations to our study. Both
surveys collected data with research questions that
focused on non-communicable diseases. Only very few
questions about sexual behavior were included. Further-
more, the participants’ HIV status or affiliations to a group
with an increased risk of STI were not known. The study
participants were not asked about the site of their infec-
tion. Because seropositivity does not distinguish between
different routes of transmission, we were unable to draw
any conclusions about the ratio of genitally to non-
genitally acquired HSV1 and HSV2 infections. Moreover,
although we measured seroprevalence, we did not investi-
gate the burden of the disease, such as the number of clin-
ical episodes, or the number of infected neonates and the
grade of severity. A number of items in the questionnaire
only covered the past year of the study participant’s life
and it is possible that their behavior had been different be-
fore that period. Making assumptions about the determi-
nants of a lifelong infection is difficult in a cross-sectional
study. Lastly, non-German citizens were underrepresented
in both surveys and we were unable to investigate the dif-
ferences in HSV1/2 seropositivity between persons with
German or non-German nationality.
Conclusions
The estimated seroprevalence of both HSV1 and HSV2
imposes large clinical and psychosocial burdens on
Germany. Therefore, the declines in HSV1 and HSV2





Fig. 3 Change of HSV1 seroprevalence in Germany between 1997–1999 and 2008–2011, according to sex and region. a in adults aged
18–65 years, b in adults aged 18–24 years, c in adults aged 25–44 years, d in adults aged 45–64 years
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benefit the nation. However, they also have a negative
consequence, because they increase the susceptibility
of sexually active people to genital HSV infections,
including pregnant women. Therefore, practitioners
should be aware of HSV infection as a differential
diagnosis for genital ulcers, and should improve the
counseling of affected patients and optimize the diag-
nosis, treatment, and prevention. This includes asking
women at their first antenatal visit if they or their
partner have had herpes, offering an explanation of
possible preventive strategies, and counseling parents
to avoid direct contact between herpetic lesions and
the neonate [35, 39]. We recommend educational in-
terventions to raise awareness of the sexual transmis-
sion route of the infection, of its possible
consequences, and of its prevention. Interventions
should especially target pregnant women and their
partners, as well as people at risk of HIV and their
partners.
It is important to continue to measure the seropreva-
lence of HSV1 and HSV2 in Germany over time to
monitor trends, and it is essential to expand the data
collected in future surveys to include a comprehen-
sive set of questions regarding sexual behavior and
HIV status. This will allow the influence of HSV
infections on the HIV epidemic (and vice versa) in
Germany to be assessed. We also encourage studies
that explore the proportions of HSV1 and HSV2
infections among genital infections in Germany and
to measure and monitor the number of neonatal HSV
infections.
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